Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer. Tsoi H, Lok J, Man EP, Cheng CN, et al. J Pathol 2023 Aug 9. doi: 10.1002/path.6157.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tsoi H, Lok J, Man EP, Cheng CN, et al. Overexpression of BQ323636.1 contributes to anastrozole resistance in AR+ve/ER+ve breast cancer. J Pathol 2023 Aug 9. doi: 10.1002/path.6157.
PMID: 37555303